Catalyst Wire Dossier Catalyst Wire Dossier

Toludesvenlafaxine hydrochloride sustained-release tablets

toludesvenlafaxine hydrochloride
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Toludesvenlafaxine hydrochloride sustained-release tablets, covering 2024-03-15 to 2025-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Venlafaxine Hydrochloride Sustained-release Tablets in Patients With Major Depression Disorder [NA]

See pricing